RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis.
Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
转移是胰腺导管腺癌(PDAC)的决定性特征之一,也是导致其预后不良的原因。在本研究中,通过体内短发夹RNA(shRNA)筛选发现棕榈酰转移酶ZDHHC20对转移性生长至关重要,而对体外增殖和迁移或小鼠原发PDAC生长没有影响。这一表型在免疫缺陷动物和NK细胞耗竭的动物中消失,表明ZDHHC20影响肿瘤细胞与先天免疫系统的相互作用。利用针对ZDHHC20特异性底物谱分析的化学遗传学平台,鉴定了该酶的多个底物。这些结果描述了棕榈酰化在促进远处转移中的作用,而这一作用无法通过体外筛选方法检测到,并鉴定了ZDHHC20促进PDAC转移的潜在效应分子。
Metastasis is one of the defining features of pancreatic ductal adenocarcinoma (PDAC) that contributes to poor prognosis. In this study, the palmitoyl transferase ZDHHC20 was identified in an in vivo short hairpin RNA (shRNA) screen as critical for metastatic outgrowth, with no effect on proliferation and migration in vitro or primary PDAC growth in mice. This phenotype is abrogated in immunocompromised animals and animals with depleted natural killer (NK) cells, indicating that ZDHHC20 affects the interaction of tumor cells and the innate immune system.
Using a chemical genetics platform for ZDHHC20-specific substrate profiling, a number of substrates of this enzyme were identified. These results describe a role for palmitoylation in enabling distant metastasis that could not have been detected using in vitro screening approaches and identify potential effectors through which ZDHHC20 promotes metastasis of PDAC.
MEMBER ACCOUNT
登录成功会直接打开下一页。